World first treatment with ‘acoustic cluster therapy’ to improve chemotherapy delivery 18 Dec 2019 The first patient has been treated, as part of a clinical trial, with an innovative new technology called Acoustic Cluster Therapy that uses microscopic clusters of bubbles and liquid droplets to enhance the delivery of chemotherapy drugs to tumours. The new therapy could improve targeting of chemotherapy and reduce doses. Find out more Show/Hide
Cancer research offers more hope than people think 09 Dec 2019 The strong public focus on a ‘cure for cancer’ is masking dramatic progress in extending the lives of patients with advanced cancer and turning it into a manageable disease long term, a YouGov poll of members of the public and cancer patients has found. Find out more Show/Hide
ICR responds to NICE approval of palbociclib for treating advanced breast cancer after hormone therapy 28 Nov 2019 The Institute of Cancer Research, London, welcomes the approval by NICE of the innovative targeted cancer treatment palbociclib for women with advanced breast cancer who have already received hormone therapy. Find out more Show/Hide
Major trial backs immunotherapy as standard first-line treatment for head and neck cancer 23 Nov 2019
ESMO 2019: Breast and ovarian cancer drug outperforms targeted hormone therapy in some men with advanced prostate cancer 30 Sep 2019
ESMO 2019: Modern chemotherapy drug better than second targeted hormone therapy against resistant prostate cancer 30 Sep 2019